CSCO Cisco
- 59.620
- +0.140+0.24%
- 59.700
- +0.080+0.13%
Cisco News
US Stock Markets Surge To Record Highs As Tech Shares Lead Rally
Synopsys (SNPS.US) annual revenue year-on-year growth of 15% hit a historic high. Q1 performance guidance is below expectations.
Synopsys announced its fourth quarter results for fiscal year 2024, with annual revenue hitting a record high, but the first quarter performance guidance fell short of analyst expectations.
Unpacking the Latest Options Trading Trends in Cisco Systems
Cisco: Architecting Sustainability in Storage Area Networks
Cisco: Cleaner Air, Healthier Buildings: How Carbon Reform Is Modernizing Indoor Environments for Health and Efficiency
Salesforce Earnings Cap a Banner Quarter for Software Stocks
S&P and Nasdaq on Track for Third Record Close This Week | Live Stock
A once-in-a-century bullish trend? Bank of America: A significant explosion in technology combined with regulatory easing, technology stocks may experience a "circuit-breaker style rise."
Bank of America stated that the valuation of technology stocks still has room for further expansion. Bank of America is selectively call on technology stocks, and data from the best-performing stocks over the past 30 years show that investors who long hold the 'right technology stocks' have achieved astonishing returns.
Haisco Pharmaceutical Group (002653.SZ): has obtained the "Notice of Drug Clinical Trial Approval" for the innovative drug HSK46575 tablets.
On December 4th, Haisco Pharmaceutical Group (002653.SZ) announced that its subsidiary, Tibet Haisco Pharmaceutical Co., Ltd., recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. The tablet is named HSK46575 Tablet and is intended for the treatment of prostate cancer. HSK46575 Tablet is a self-developed oral, potent, and highly selective small molecule inhibitor designed for the treatment of prostate cancer. Preclinical research results indicate that this product has a clear target, precise efficacy, and good safety profile, making it a highly promising small molecule drug with significant potential for development. The benefits/risks of clinical application.
Will 2025 no longer be the era of the magnificent 7? Bank of America is bullish on this type of stocks...
①The chief strategist of Bank of America predicts that cyclical stocks (such as csi commodity equity index, construction, and infrastructure) will rise strongly, as investors will flow into the "old economy" sector; ②She believes that the USA economy is ready for a new spending cycle, and expects the s&p 500 index to rise to 6666 points next year.
Cisco Systems, Inc. (CSCO) Management Presents at 2024 UBS Global Technology and AI Conference (Transcript)
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
The Top 20 Technology Stocks Ranked by Quant
Cisco Systems To Present At 2024 UBS Global Technology And AI Conference; Webcast At 12:55 PM ET
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
SmarTrak.Ai Accelerates Growth With Strategic Funding and Major Contracts
Insider Sale: SVP & Chief Acctg Officer of $CSCO (CSCO) Sells 4,881 Shares
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
December Starts With a Mixed Market | Live Stock
A SoftBank Insider Describes His Wild Ride
Analysis
Price Target
No Data
No Data
